Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determine the Effects of COL-101 Administered Once Daily With Metronidazole Topical Gel, 1% Versus Doxycycline Hyclate 100 mg Administered Once Daily With Metronidazole Topical Gel, 1% in Patients With Moderate to Severe Rosacea

NCT00495313 is registered in ClinicalTrials.gov with CollaGenex Pharmaceuticals as lead sponsor.

NCT NCT00495313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00495313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determine the Effects of COL-101 Administered Once Daily With Metronidazole Topical Gel, 1% Versus Doxycycline Hyclate 100 mg Administered Once Daily With Metronidazole Topical Gel, 1% in Patients With Moderate to Severe Rosacea
Lead sponsor
CollaGenex Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2007
Completion date
December 31, 2007
Enrollment
91 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea